Search results
Results from the WOW.Com Content Network
Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate gland. [1] Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control. [1]
In many developing countries cancer incidence, insofar as this can be measured, appears much lower, most likely because of the higher death rates due to infectious disease or injury. With the increased control over malaria and tuberculosis in some Third World countries, incidence of cancer is expected to rise.
Screening for prostate cancer may include a digital rectal exam, where the clinician assesses for an enlarged prostate, and/or a blood test to measure a prostate-specific antigen (PSA) level.
Prostate cancer is the most diagnosed cancer in men in over half of the world's countries, and the leading cause of cancer death in men in around a quarter of countries. [91] Prostate cancer is rare in those under 40 years old, [92] and most cases occur in those over 60 years, [2] with the average person diagnosed at 67. [93]
An enlarged prostate doesn’t always cause symptoms, but when it does, they can be annoying. And some men have more trouble than others. A look at the condition, also known as benign prostatic ...
The most common symptom of an enlarged prostate are changes in how you pee. This is because when the prostate is enlarged, it puts pressure on the bladder and the urethra. According to Prostate ...
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. [27] Most prostate cancers are slow growing; however, some grow relatively quickly. [28] [29] The cancer cells may spread from the prostate to other areas of the body, particularly the bones and lymph nodes. [30] It may initially cause no ...
The prostate is a gland that is found under the rectum and below the bladder in the male reproductive system. [5] Five randomized controlled trials were conducted to determine whether prostate cancer screening reduces mortality associated with prostate cancer where 341,342 participants within the age range of 45–80 years were included in the ...